158 related articles for article (PubMed ID: 1354412)
21. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
Wormsley SB; Baird SM; Gadol N; Rai KR; Sobol RE
Blood; 1990 Jul; 76(1):123-30. PubMed ID: 1694698
[TBL] [Abstract][Full Text] [Related]
22. Induction of plasmacytoid and hairy cell features by phorbol esters (TPA) in B-lymphoma cells: attempted correlation with disease activity.
Gazitt Y; Leizerowitz R; Polliack A
Hematol Oncol; 1988; 6(4):307-18. PubMed ID: 3263307
[TBL] [Abstract][Full Text] [Related]
23. Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia.
Caligaris-Cappio F; Pizzolo G; Chilosi M; Bergui L; Semenzato G; Tesio L; Morittu L; Malavasi F; Gobbi M; Schwarting R
Blood; 1985 Nov; 66(5):1035-42. PubMed ID: 3876853
[TBL] [Abstract][Full Text] [Related]
24. Hairy cell leukemia variant: fact or fiction.
Cessna MH; Hartung L; Tripp S; Perkins SL; Bahler DW
Am J Clin Pathol; 2005 Jan; 123(1):132-8. PubMed ID: 15762289
[TBL] [Abstract][Full Text] [Related]
25. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
Aljurf M; Cornbleet PJ; Michel F
Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
[TBL] [Abstract][Full Text] [Related]
26. Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype.
Segel GB; Woodlock TJ; Xu J; Li L; Felgar RE; Ryan DH; Lichtman MA; Wang N
Blood Cells Mol Dis; 2003; 30(3):277-87. PubMed ID: 12737946
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique.
Vardiman JW; Gilewski TA; Ratain MJ; Bitter MA; Bradlow BA; Golomb HM
Am J Clin Pathol; 1988 Sep; 90(3):250-6. PubMed ID: 2458031
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
29. Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias.
Takeuchi H; Katayama I
Leuk Lymphoma; 1993 Jun; 10(3):209-16. PubMed ID: 8220119
[TBL] [Abstract][Full Text] [Related]
30. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
31. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
32. Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: case report.
Ahmad I; Al-Katib AM; Beck FW; Mohammad RM
Clin Cancer Res; 2000 Apr; 6(4):1328-32. PubMed ID: 10778958
[TBL] [Abstract][Full Text] [Related]
33. Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kuratsune H; Owada MK; Tokumine Y; Tagawa S; Nojima J; Shibano M; Nishimori Y; Morita T; Machii T; Kitani T
Leukemia; 1990 Oct; 4(10):700-3. PubMed ID: 2214873
[TBL] [Abstract][Full Text] [Related]
34. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
Carlsson M; Matsson P; Rosén A; Sundström C; Tötterman TH; Nilsson K
Leukemia; 1988 Nov; 2(11):734-44. PubMed ID: 3263557
[TBL] [Abstract][Full Text] [Related]
35. CD5+, CD11c+, CD20+ hairy cell leukemia.
Heimann PS; Vardiman JW; Stock W; Platanias LC; Golomb HM
Blood; 1991 Apr; 77(7):1617-9. PubMed ID: 1706957
[No Abstract] [Full Text] [Related]
36. Trisomy 12 in chronic lymphocytic leukemia and hairy cell leukemia: a cytogenetic and interphase cytogenetic study.
Cuneo A; Bigoni R; Balboni M; Carli MG; Piva N; Fagioli F; Latorraca A; Wlodarska I; van den Berghe H; Castoldi G
Leuk Lymphoma; 1994 Sep; 15(1-2):167-72. PubMed ID: 7858495
[TBL] [Abstract][Full Text] [Related]
37. In-vitro induction of some features of hairy cell leukemia in chronic lymphocytic leukemia and immunocytoma cells.
Ziegler-Heitbrock HW; Dörken B; Munker R; Riethmüller G; Thierfelder S; Thiel E
Blut; 1985 Jan; 50(1):29-31. PubMed ID: 3967098
[TBL] [Abstract][Full Text] [Related]
38. Expression of tartrate-resistant acid phosphatase in B-CLL treated with phorbol ester or phorbol ester plus calcium ionophore.
Drexler HG; Brenner MK; Gignac SM; Hoffbrand AV
Eur J Haematol; 1988 Sep; 41(3):250-7. PubMed ID: 3141210
[TBL] [Abstract][Full Text] [Related]
39. A comparison of membrane marker phenotypes in hairy-cell leukemia and phorbol-ester induced B-cll cells using monoclonal antibodies.
Herrmann F; Dörken B; Ludwig WD; Schwarting R
Leuk Res; 1985; 9(5):529-36. PubMed ID: 2409407
[TBL] [Abstract][Full Text] [Related]
40. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
